Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Extended recombinant PTH treatment demonstrates good efficacy for hypoparathyroidism

May 26, 2014

Gilead's GS-5806 effective in phase IIa RSV trial

May 26, 2014

Pfizer researchers design nicotine vaccines with higher avidity

May 26, 2014

Empagliflozin evaluated in patients with diabetes and hypertension in phase III trials

May 23, 2014

IBI-302 investigated for AMD in vitro and in vivo

May 23, 2014

Novel azithromycin derivative identified for pulmonary inflammation

May 23, 2014

Interferon alpha inhibitor shows promise for the treatment of HIV encephalitis

May 23, 2014

Urothelial carcinogen resistance model developed in rats

May 23, 2014

Toxin-specific MAbs show efficacy in hamster model of CDAD

May 23, 2014

Clinical trial results presented for liraglutide for weight management and diabetes

May 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...